UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
2005, Heritage, ISBN 0802038719, xii, 225
Tolkien, J. R. R. 1892-1973 KnowledgeMythology | Middle Earth (Imaginary place) | Language and languages in literature | Mythology in literature | Tolkien, J. R. R. 1892-1973 Criticism and interpretation | Tolkien, J. R. R. 1892-1973 KnowledgeLiterature | Tolkien, J. R. R. 1892-1973 KnowledgeLanguage and languages | Tolkien, J. R. R. 1892-1973 Characters | Literature | Criticism and interpretation | Characters | Language and languages | Language & Literature | Tolkien, J.R.R. (John Ronald Reuel), 1892–1973 | Mythology | Knowledge | Twentieth Century | Tolkien, J. R. R | Norse Mythology | Authors | English Literature | Celtic Mythology | Invented Languages
Book
2011, ISBN 1611470641, 310
Book
1977, ISBN 9780719006890, vi, 205
Book
2012, T & T Clark library of biblical studies, ISBN 0567027171, Volume 484, xxxii, 540
Book
2010, ISBN 1405161698, 4362
eBook
PharmacoEconomics, ISSN 1170-7690, 07/2020, Volume 38, Issue 7, pp. 765 - 776
Journal Article
Journal of Alzheimer's disease, ISSN 1387-2877, 12/2015, Volume 49, Issue 4, pp. 1179 - 1187
investigational treatment | PET scan | Alzheimer's disease | biomarkers | oxidative stress | cognitive disorder | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Severity of Illness Index | Brain - diagnostic imaging | Peptide Fragments - cerebrospinal fluid | Humans | Nootropic Agents - pharmacokinetics | Alzheimer Disease - drug therapy | Nootropic Agents - therapeutic use | Male | Treatment Outcome | Positron-Emission Tomography | tau Proteins - cerebrospinal fluid | Biomarkers - blood | Nootropic Agents - adverse effects | Benzothiazoles - pharmacokinetics | Brain - drug effects | Brain - metabolism | Neuropsychological Tests | Amyloid beta-Peptides - cerebrospinal fluid | Glucose - metabolism | Female | Aged | Benzothiazoles - therapeutic use | Biomarkers - cerebrospinal fluid | Benzothiazoles - adverse effects | Index Medicus | Biomarkers | Cognitive Disorder | PET Scan | Oxidative Stress | Alzheimer Disease | Investigational Treatment
Journal Article
The Journal of craniofacial surgery, ISSN 1049-2275, 07/2020, Volume Publish Ahead of Print
Journal Article
Water resources research, ISSN 0043-1397, 11/2015, Volume 51, Issue 11, pp. 9029 - 9052
Journal Article
DNA and cell biology, ISSN 1044-5498, 01/2021, Volume 40, Issue 1, pp. 70 - 79
Biochemistry & Molecular Biology | Genetics & Heredity | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Cell Line | Up-Regulation | Colonic Neoplasms - genetics | Receptors, G-Protein-Coupled - metabolism | Thrombospondins - genetics | Humans | Intercellular Signaling Peptides and Proteins - genetics | Ubiquitin-Protein Ligases - metabolism | Male | Colonic Neoplasms - metabolism | Breast Neoplasms - metabolism | Intercellular Signaling Peptides and Proteins - metabolism | Adenocarcinoma - metabolism | Breast Neoplasms - genetics | MCF-7 Cells | Female | Adenocarcinoma - genetics | Thrombospondins - metabolism | Wnt Signaling Pathway | Cell proliferation | G protein-coupled receptors | Wnt protein | Transcription | Frizzled protein | Epithelial cells | Leucine | Kinases | Genetic screening | Proteins | Signal transduction | Receptors | Colon | Binding | Translocation | Cell survival | Breast cancer | Gene expression | Survival | Adenomatous polyposis coli | Signaling | β-Catenin | Receptor mechanisms | Mutation | Cancer
Journal Article
Journal of molecular and cellular cardiology, ISSN 0022-2828, 11/2018, Volume 124, pp. 114 - 114
Journal Article
Journal of antimicrobial chemotherapy, ISSN 0305-7453, 2017, Volume 72, Issue 6, pp. 1760 - 1768
Pharmacology & Pharmacy | Infectious Diseases | Life Sciences & Biomedicine | Microbiology | Science & Technology | HIV Infections - prevention & control | Triazoles - administration & dosage | Triazoles - adverse effects | Humans | Male | Cyclohexanes - administration & dosage | Anti-HIV Agents - administration & dosage | Young Adult | Cyclohexanes - therapeutic use | Ritonavir - adverse effects | Post-Exposure Prophylaxis | Ritonavir - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination - therapeutic use | Female | Cyclohexanes - adverse effects | Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination - adverse effects | Triazoles - therapeutic use | HIV Protease Inhibitors - adverse effects | Ritonavir - administration & dosage | HIV-1 - drug effects | Anti-HIV Agents - adverse effects | HIV Infections - virology | CD4 Lymphocyte Count | HIV Protease Inhibitors - administration & dosage | HIV Protease Inhibitors - therapeutic use | Medication Adherence | Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination - administration & dosage | Lopinavir - administration & dosage | HIV Infections - drug therapy | Lopinavir - therapeutic use | Drug Combinations | Lopinavir - adverse effects | Index Medicus
Journal Article
AIDS (London), ISSN 0269-9370, 03/2014, Volume 28, Issue 5, pp. 689 - 697
Prognosis | HIV | R-CHOP chemotherapy | Survival | Outcome | Diffuse large B-cell lymphoma | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Science & Technology | Virology | Hematologic and hematopoietic diseases | Immunopathology | Infectious diseases | Viral diseases | Viral diseases of the lymphoid tissue and the blood. Aids | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Human viral diseases | Immunodeficiencies. Immunoglobulinopathies | Immunodeficiencies | Doxorubicin - therapeutic use | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - pathology | Humans | Middle Aged | Male | Treatment Outcome | Cyclophosphamide - therapeutic use | Lymphoma, Large B-Cell, Diffuse - mortality | Young Adult | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | HIV Infections - complications | Survival Analysis | Vincristine - therapeutic use | Adult | Female | Aged | Prednisone - therapeutic use | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Index Medicus | AIDS/HIV
Journal Article
Journal of medicinal chemistry, ISSN 0022-2623, 1992, Volume 35, Issue 16, pp. 3081 - 3084
Journal Article
The Journal of biological chemistry, ISSN 0021-9258, 10/2011, Volume 286, Issue 43, pp. 37063 - 37066
Life Sciences & Biomedicine | Biochemistry & Molecular Biology | Science & Technology | Humans | ELAV Proteins - metabolism | MicroRNAs - metabolism | MicroRNAs - genetics | 3' Untranslated Regions - physiology | HeLa Cells | Genomics - methods | Response Elements - physiology | ELAV Proteins - genetics | Index Medicus | Gene Regulation | Alternative Splicing | HuR | RNA Abundance | Reports | Cancer Biology | RNA-binding Protein | ELAVL1
Journal Article
Contemporary clinical trials, ISSN 1551-7144, 2013, Volume 36, Issue 2, pp. 555 - 564
Hematology, Oncology and Palliative Medicine | Cardiovascular | Disability | Aging | Clinical trial | Aspirin | Primary prevention | Dementia | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Double-Blind Method | Risk Assessment | United States | Cardiovascular Diseases - prevention & control | Humans | Mortality | Male | Neoplasms - prevention & control | Cognitive Dysfunction - prevention & control | Aspirin - administration & dosage | Activities of Daily Living | Gastrointestinal Hemorrhage - chemically induced | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Depression - prevention & control | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Aspirin - adverse effects | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | Disabled Persons - statistics & numerical data | Female | Aged | Aspirin - therapeutic use | Australia | Tablets, Enteric-Coated | Dementia - prevention & control | Clinical trials | Melanoma | Index Medicus | clinical trial | primary prevention | dementia | aging | disability
Journal Article